![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
Financial & competing interests disclosure
NV Dhurandhar has the following approved US patents: US6127113, viral obesity methods and compositions; US6664050, viral obesity methods and compositions; and US8008436B2, adenovirus 36 E4orf1 gene and protein and their uses. He has filed the following patents: 05P09, Ad-36 E4 orf-1, E1A and obesity and diabetes; US 2010.61/362,443 and Taiwan Patent number 100124173, adenovirus Ad‑36 E4orf1 protein for prevention and treatment of nonalcoholic fatty liver disease; and a provisional patent for enhanced glycemic control using Ad‑36E4orf1 and AKT1 inhibitors. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.